Lv31
302 积分 2024-06-26 加入
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease
1小时前
已完结
LRRK2-targeting antisense oligonucleotide in Parkinson’s disease: a phase 1 randomized controlled trial
16天前
已完结
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease
16天前
已完结
Effect of selective LRRK2 kinase inhibition on nonhuman primate lung
16天前
已完结
LRRK2 in Parkinson disease: challenges of clinical trials
16天前
已完结
LRRK2 kinase in Parkinson's disease
16天前
已完结
Mechanistic Pharmacokinetics and Pharmacodynamics of GalNAc-siRNA: Translational Model Involving Competitive Receptor-Mediated Disposition and RISC-Dependent Gene Silencing Applied to Givosiran
26天前
已完结
Mechanistic Insights into Hybridization-Based Off-Target Activity of GalNAc-siRNA Conjugates
1个月前
已完结
LBO-004 Safety, pharmacokinetics, and clinical activity of HRX215 after hepatectomy due to colon carcinoma metastases: interim results from pilot cohort of a 1b/2a clinical trial
3个月前
已完结
Current drug options for raising HDL cholesterol
3个月前
已完结
皖公网安备34019202002308
